Home/Snyder Biomedical/Robert W. Snyder, MD, PhD
RW

Robert W. Snyder, MD, PhD

Co-Founder

Snyder Biomedical

Snyder Biomedical Pipeline

DrugIndicationPhase
Oral L-DOPA/CarbidopaAdjunctive Treatment for Neovascular Age-Related Macular Degeneration (nAMD)Proof-of-Concept